understanding patient-reported outcome measures in huntington disease: at what point is cognitive...

22
Noelle E. Carlozzi, Ph.D. Paulsen, JS, Stout, J, Nance, MA, Perlmutter, JS, Ross, CA, Goodnight, SM, Miner, JA, Dayalu, P, McCormack, MK, Quaid, KA, Perlman, S, Hahn, EA, Lai, J-S, Downing, NR, Kratz, AL, Barton, SK, Ready, R, Frank, S, Cella, D, Gershon, RC, Shoulson, I, Marin, H, Geschwind, MD, Rao, SM, & Schilling, SG November 4, 2016 UNDERSTANDING PATIENT-REPORTED OUTCOME MEASURES IN HUNTINGTON DISEASE: AT WHAT POINT IS COGNITIVE IMPAIRMENT RELATED TO POOR MEASUREMENT RELIABILITY?

Upload: huntington-study-group

Post on 21-Jan-2017

272 views

Category:

Health & Medicine


1 download

TRANSCRIPT

Page 1: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

Noelle E. Carlozzi, Ph.D.

Paulsen, JS, Stout, J, Nance, MA, Perlmutter, JS, Ross, CA, Goodnight, SM, Miner, JA, Dayalu, P, McCormack, MK, Quaid, KA, Perlman, S, Hahn, EA, Lai, J-S, Downing, NR, Kratz, AL, Barton, SK, Ready, R, Frank, S, Cella, D,

Gershon, RC, Shoulson, I, Marin, H, Geschwind, MD, Rao, SM, & Schilling, SG

November 4, 2016

UNDERSTANDING PATIENT-REPORTED OUTCOME MEASURES IN HUNTINGTON DISEASE: AT WHAT POINT IS

COGNITIVE IMPAIRMENT RELATED TO POOR MEASUREMENT RELIABILITY?

Page 2: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

WHAT IS A PATIENT REPORTED OUTCOME (PRO) MEASURE?

Page 3: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

PRO MEASURES COMMONLY ASSESS HEALTH-RELATED QUALITY OF LIFE

PHYSICAL EMOTIONAL SOCIAL

Page 4: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

A PRO MEASUREMENT SYSTEM THAT IS SPECIFIC TO HD

AnxietyAngerDepressionEmotional & Behavioral DyscontrolPositive Affect and Well-BeingLower Extremity Function/MobilityUpper Extremity Function/ADLsApplied Cognition-Executive FunctioningApplied Cognition-General ConcernsStigmaAbility to Participate in Social Roles andActivitiesSatisfaction with Social Roles andActivities

ChoreaDifficulties with Speech & SwallowingEnd of Life Issues Concern with Death and Dying Meaning and Purpose

HDQLIFE

Generic Domains(Neuro-QoL & PROMIS) HD-Specific Domains

Figure 1. Components of the HDQLIFE Measurement System

Carlozzi, N.E., et al. (2016): • HDQLIFE: Development and assessment of health-related quality of life in Huntington disease (HD). Quality of Life Research, 25(10), 2441-2455.• New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient reported outcomes measurement

system). Quality of Life Research, 25(10), 2403-2415.• The development of a new computer adaptive test to evaluate chorea in Huntington Disease: HDQLIFE Chorea. Quality of Life Research, 25(10), 2429-2439.• HDQLIFE: The development of two new computer adaptive tests for use in Huntington disease, Speech Difficulties and Swallowing Difficulties. Quality of Life Research, 25(10), 2417-2427.

Page 5: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

BACKGROUND

• PROs should be both reliable (i.e., repeatable) and valid (i.e., measure what was intended).

• Symptom progression in HD often includes cognitive decline, especially in the later stages.

• Can we determine when cognitive impairment may preclude PRO responding (i.e., large error variance and low reliability)?

Page 6: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

HYPOTHESES

• Items on PROs should not exhibit item bias.

• PROs should demonstrate moderate relationships with observer reports of similar constructs.

• The variability and reliability for PROs should meet minimally acceptable standards.

Page 7: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

SAMPLE CHARACTERISTICS

• N = 506 participants• 38.8% prodromal

• 39.0% early-stage HD

• 22.5% late-stage HD

• Average age 49.0 (SD = 13.2)

• 58.5% female

• 95.3% Caucasian

Page 8: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

MEASURES

HDQLIFE PROs:Chorea (34 items)

Speech Difficulties (27 items)

Swallowing Difficulties (16 items)

UHDRS clinician-rated assessments:Total Functional Capacity

Total Motor Score

Stroop (Color Naming, Word Reading, and Interference)

Symbol Digit Modalities Test

Page 9: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

ITEM BIAS

• Item bias was assessed using differential item functioning (DIF) both across HD stage and relative to cognitive performance.

• In general, items should not exhibit DIF. Some degree of DIF is considered acceptable. Some types of DIF are more problematic than others.

Page 10: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

ITEM BIAS RESULTS

• Most items were free from DIF• Chorea: no items consistently exhibited DIF; when DIF was present it was minimal

• Speech: 5 items exhibited DIF across cognitive tests and staging; no items consistently demonstrated non-uniform DIF

• Swallowing: 4 items consistently exhibited DIF across cognitive tests and staging; no items consistently exhibited non-uniform DIF

• Overall DIF was minimal

Page 11: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

RELATIONSHIPS BETWEEN PROS AND CLINICIAN-RATED SYMPTOMS

• Pearson correlations between self-report and associated clinician ratings were examined.

• We expect moderate agreement between respondents (r’s between 0.40 and 0.60).

Page 12: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

RELATIONSHIPS BETWEEN SELF-REPORT AND CLINICIAN RATINGS

PRO MeasuresProdromal Early-HD Late-HD Combined

Composite Scores

Chorea

Speech

Swallowing

Chorea

Speech

Swallowing

Chorea

Speech

Swallowing

Chorea

Speech

Swallowing

Clinician-rated Total Motor Score

.40 .22 .31 .31 .21 .27 .22 .28 .07 .66 .54 .50

Page 13: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

PSYCHOMETRIC RELIABILITY OF PROS• Three separate sets of regression models were examined to

determine the psychometric reliability of the PROs1. A simple linear regression model: split half reliabilities were compared

2. A heterogeneous variance model for HD stage: model was fit with different variances for each HD stage

3. A heterogeneous variance model for cognition: model was fit for variance in total cognition.

Item 1

Item 2

Item 3

Item 4

Item 5

Item 6

Item 3 Item 5Item 4

Item 1 Item 2 Item 6

Split-Half Correlations

.91

Page 14: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

Table 4: Estimated PRO Reliabilities by HD StageMeasure Prodromal Early Late

HDQLIFE Chorea 0.98 0.86 0.72HDQLIFE Speech 0.98 0.85 0.69

HDQLIFE Swallowing 0.95 0.79 0.71

• Reliability standards:

• 0.70 = unacceptable˂• 0.70 - 0.79 = acceptable

• 0.80 – 0.89 = good

• ≥ 0.90 = excellent

Page 15: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

SIMPLE REGRESSION MODELS

Table 3: Simple Regression ModelsPRO Measure beta R2 tChorea 0.97 0.94 83.22Speech 0.92 0.92 70.93Swallowing 1.24 0.84 49.18Note. all p <.0001

Page 16: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

MODEL FIT RESULTS FOR PRO MEASURESModel DF AIC BIC Chi-Square

HDQLIFE Chorea

Simple Regression 3 2291.75 2303.90

Heterogeneous - Cognition 4 2112.89 2129.09 180.86*

Heterogeneous - HD Stage 5 2096.93 2117.18 198.81*

HDQLIFE Speech DifficultiesSimple Regression 3 2330.83 2343.12

Heterogeneous -Cognition 4 2239.79 2256.19 93.03*

Heterogeneous - HD Stage 5 2206.81 2227.30 128.02*

HDQLIFE Swallowing Difficulties Simple Regression 3 2136.32 2148.63

Heterogeneous -Cognition 4 1993.47 2009.88 144.85*

Heterogeneous - HD Stage 5 2038.47 2058.94 101.85*

Note. * p < .0001

The heterogeneous models provide a better fit than the simple regression model

Page 17: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

0 50 100 150 200 250 300 350 400 450-20

-15

-10

-5

0

5

10

15

20 Residual Plot: Chorea

Cognition Total Scores

Resi

dual

Early HDHD

Late HDHD

variability

variability

variability

Prodromal HDHD

Total Cognition Scores

Page 18: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

CUTOFF SCORES FOR RELIABILITY

Total Cognition Scores (SDMT + Stroop)

PRO Reliability > 0.7“adequate”

Reliability > 0.8“good”

Chorea <77 < 136Speech N/A <109Swallowing <134 <179Note. M = 144.56 (SD = 77.31) for Total Cognition Scores for the combined sample

Page 19: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

SUMMARY & CONCLUSIONS• As HD progresses and cognition declines, high error variance and low

reliability can negatively affected the psychometric properties of PRO measures.

• Although minimal standards for reliability on PRO measures was met for all HD groups, clinical cutoffs on cognitive tests can be used to maximize PRO reliability.

• In cases where cognitive scores do not meet critical cutoffs, PRO measures should only be considered in conjunction with other assessments.

• Recommended clinical cutoffs differed for different measures. This suggests that cognitive complexity may vary across PRO measures.

Page 20: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

QUESTIONS?

Page 21: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

ACKNOWLEDGEMENTSFunding:• National Institute of Neurological Disorders and Stroke: R01NS077946,

R03NS065194, R01NS040068, & R01NS077946• National Center for Advancing Translational Sciences UL1TR000433• CHDI Foundation• HD Center Grant from the NJ Department of Health and Senior Services

HDQLIFE Site Investigators and Coordinators: Praveen Dayalu, Amy Austin (University of Michigan, Ann Arbor, MI); Courtney Shadrick, Amanda Miller (University of Iowa, Iowa City, IA); Kimberly Quaid, Melissa Wesson (Indiana University, Indianapolis, IN); Christopher Ross, Gregory Churchill, Mary Jane Ong (Johns Hopkins University, Baltimore, MD); Susan Perlman, Brian Clemente (University of California -Los Angeles, Los Angeles, CA); Michael McCormack, Humberto Marin, Allison Dicke (Rutgers University, Piscataway, NJ); Joel Perlmutter, Stacey Barton, Shineeka Smith (Washington University, St. Louis, MO); Martha Nance, Pat Ede (Struthers Parkinson’s Center); Anwar Ahmed, Christine Reece, Lyla Mourany (Cleveland Clinic Foundation, Cleveland, OH); Michael Geschwind, Joseph Winer (University of California – San Francisco, San Francisco, CA); David Cella, Richard Gershon, Elizabeth Hahn, Jin-Shei Lai (Northwestern University – Chicago, IL)

Page 22: Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability

CONTACT US

• Phone: 734 – 764 - 0644

• E-mail: [email protected]

• https://sites.google.com/site/codaresearch/